| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.07T | 1.05T | 985.99B | 911.41B | 767.96B |
| Gross Profit | 168.91B | 142.08B | 130.51B | 119.61B | 101.82B |
| EBITDA | 52.18B | 60.06B | 58.57B | 53.97B | 44.39B |
| Net Income | 32.52B | 27.47B | 23.22B | 18.58B | 15.99B |
Balance Sheet | |||||
| Total Assets | 733.01B | 708.99B | 741.21B | 687.88B | 643.49B |
| Cash, Cash Equivalents and Short-Term Investments | 58.42B | 56.78B | 53.43B | 79.46B | 91.42B |
| Total Debt | 183.05B | 203.26B | 235.76B | 248.57B | 160.28B |
| Total Liabilities | 509.53B | 520.85B | 565.21B | 544.45B | 444.21B |
| Stockholders Equity | 208.39B | 173.94B | 159.32B | 128.53B | 159.48B |
Cash Flow | |||||
| Free Cash Flow | 53.24B | 49.26B | 31.97B | -4.95B | 11.77B |
| Operating Cash Flow | 57.66B | 58.33B | 35.58B | -296.00M | 15.38B |
| Investing Cash Flow | -12.83B | 1.49B | -29.72B | -78.25B | -10.54B |
| Financing Cash Flow | -46.00B | -54.78B | -32.80B | 66.31B | 4.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥358.00B | 8.73 | 11.34% | 3.38% | 4.23% | -14.22% | |
73 Outperform | ¥96.22B | 8.02 | ― | 3.74% | -3.93% | 3.02% | |
69 Neutral | ¥350.65B | 10.68 | ― | 3.13% | 1.59% | 18.87% | |
67 Neutral | ¥6.54T | 17.59 | 13.49% | 2.10% | 12.15% | 2.20% | |
67 Neutral | ¥431.31B | 8.93 | ― | 3.37% | 2.89% | 17.83% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥968.55B | 10.36 | 11.17% | 3.24% | 9.87% | -3.44% |